NATIONAL BREAST CANCER FOUNDATION (NBCF) OUTLINES PINK HORIZON RESEARCH STRATEGY AT BREAST CANCER FORUM Breast Cancer Awareness Month demonstrates integral role of NBCF in research and clinical support
Filmed in Brisbane, Queensland | November 2024
Associate Professor Cleola Anderiesz, Chief Executive Officer of the National Breast Cancer Foundation, leads an organisation dedicated to funding world-class breast cancer research in Australia. The Foundation has a bold vision of achieving zero deaths from breast cancer.
Every October, during Breast Cancer Awareness Month, the foundation uses this time to raise awareness about breast cancer and its impact in Australia. It also emphasises the critical need for funding breast cancer research to improve outcomes.
The National Breast Cancer Foundation collaborates with researchers, providing essential funding while also engaging them, clinicians, and consumers to establish research priorities.
Australian Health Journal met with Assoc Prof Anderiesz to hear of the new 5 year Pink Horizon research strategy. Those with lived experience of breast cancer, along with researchers, clinicians, and other funding organisations, have contributed to the development of the foundation’s new five-year Pink Horizon research strategy. This ambitious plan aims to invest $125 million to accelerate research efforts towards the vision of ending deaths from breast cancer.
Recently, Assoc Professor Anderiesz presented at the Public Breast Cancer Research Forum hosted by The University of Queensland and the Translational Research Institute, where she highlighted the accomplishments of the National Breast Cancer Foundation over the past 30 years. During this time, the Foundation has invested over $200 million into more than 600 research projects across Australia, supporting 1,800 researchers at 120 institutes to advance impactful breast cancer research.
Professor Anderiesz believes it is essential for all members of the breast cancer community to consistently seek opportunities to raise awareness about the disease’s impact. This awareness should extend beyond October and include efforts to inform primary care physicians and specialists. Additionally, there is a need to promote groundbreaking research and advocate for changes in policy and care to improve outcomes for individuals affected by breast cancer.
-
Co-design, adoption and interoperability
In October CEBIT AUSTRALIA held it’s yearly technology related conference. Australian Health Journal’s reporter Anne Dao spoke with health technology thought leaders on what needs to be consider in Co-Design, Adoption and Interoperability of technology aided healthcare delivery
-
Journey of an ICU Nurse on International Nurses Day 2025
Kate Leigh is a clinical nurse at the Sir Charles Gairdner Hospital Intensive Care Unit in Perth, Western Australia, with seven and a half years of experience in intensive care, having started her career in London as a new graduate nurse. Initially focused on haematology, she found herself drawn to ICU after meeting a confident and knowledgeable nurse during a discharge. Inspired by his expertise and assuredness, Kate decided to pursue a transfer to Critical Care after seeing an internal advertisement that highlighted educational opportunities and professional development programs.
-
The Northernmost Pharmacist in Australia
Carli Berrill is a Co-Owner and Pharmacist of two pharmacies in Far North Queensland, including one on Thursday Island in Torres Strait, which is the most northern pharmacy in Australia.
Her role with the Thursday Island Pharmacy is to provide essential health and pharmacy services to 15 communities, including remote islands south of Papua New Guinea. The role for the community is the important ‘constant’ in being a trusted and familiar healthcare professional.
